Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 4
2019 2
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Peptide-guided nanoparticles for glioblastoma targeting.
Säälik P, Lingasamy P, Toome K, Mastandrea I, Rousso-Noori L, Tobi A, Simón-Gracia L, Hunt H, Paiste P, Kotamraju VR, Bergers G, Asser T, Rätsep T, Ruoslahti E, Bjerkvig R, Friedmann-Morvinski D, Teesalu T. Säälik P, et al. Among authors: tobi a. J Control Release. 2019 Aug 28;308:109-118. doi: 10.1016/j.jconrel.2019.06.018. Epub 2019 Jun 27. J Control Release. 2019. PMID: 31255690
Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide.
Scodeller P, Simón-Gracia L, Kopanchuk S, Tobi A, Kilk K, Säälik P, Kurm K, Squadrito ML, Kotamraju VR, Rinken A, De Palma M, Ruoslahti E, Teesalu T. Scodeller P, et al. Among authors: tobi a. Sci Rep. 2017 Nov 7;7(1):14655. doi: 10.1038/s41598-017-14709-x. Sci Rep. 2017. PMID: 29116108 Free PMC article.
Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery.
Lingasamy P, Tobi A, Haugas M, Hunt H, Paiste P, Asser T, Rätsep T, Kotamraju VR, Bjerkvig R, Teesalu T. Lingasamy P, et al. Among authors: tobi a. Biomaterials. 2019 Oct;219:119373. doi: 10.1016/j.biomaterials.2019.119373. Epub 2019 Jul 19. Biomaterials. 2019. PMID: 31374479 Free article.
Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth.
Sharma S, Kotamraju VR, Mölder T, Tobi A, Teesalu T, Ruoslahti E. Sharma S, et al. Among authors: tobi a. Nano Lett. 2017 Mar 8;17(3):1356-1364. doi: 10.1021/acs.nanolett.6b03815. Epub 2017 Feb 17. Nano Lett. 2017. PMID: 28178415 Free PMC article.
Tumor-penetrating peptide for systemic targeting of Tenascin-C.
Lingasamy P, Tobi A, Kurm K, Kopanchuk S, Sudakov A, Salumäe M, Rätsep T, Asser T, Bjerkvig R, Teesalu T. Lingasamy P, et al. Among authors: tobi a. Sci Rep. 2020 Apr 2;10(1):5809. doi: 10.1038/s41598-020-62760-y. Sci Rep. 2020. PMID: 32242067 Free PMC article.
Ratiometric in vivo auditioning of targeted silver nanoparticles.
Toome K, Willmore AA, Paiste P, Tobi A, Sugahara KN, Kirsimäe K, Ruoslahti E, Braun GB, Teesalu T. Toome K, et al. Among authors: tobi a. Nanoscale. 2017 Jul 20;9(28):10094-10100. doi: 10.1039/c7nr04056c. Nanoscale. 2017. PMID: 28695222 Free PMC article.
Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles.
Hunt H, Simón-Gracia L, Tobi A, Kotamraju VR, Sharma S, Nigul M, Sugahara KN, Ruoslahti E, Teesalu T. Hunt H, et al. Among authors: tobi a. J Control Release. 2017 Aug 28;260:142-153. doi: 10.1016/j.jconrel.2017.06.005. Epub 2017 Jun 8. J Control Release. 2017. PMID: 28603028 Free PMC article.
Exposed CendR Domain in Homing Peptide Yields Skin-Targeted Therapeutic in Epidermolysis Bullosa.
Pemmari T, Ivanova L, May U, Lingasamy P, Tobi A, Pasternack A, Prince S, Ritvos O, Makkapati S, Teesalu T, Cairo MS, Järvinen TAH, Liao Y. Pemmari T, et al. Among authors: tobi a. Mol Ther. 2020 Aug 5;28(8):1833-1845. doi: 10.1016/j.ymthe.2020.05.017. Epub 2020 May 20. Mol Ther. 2020. PMID: 32497513 Free article.